Information about ReWind Therapeutics
My details
*
*
*

ReWind Therapeutics (SA)

Company information

Status
Active

Enterprise number

BE0682.626.216

VAT liability
Yes
Established
29-09-2017
Last balance sheet year
2024
Company size
Medium-sized 8,6 FTE
Principal activity
Research and experimental development on biotechnology
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

7-day free trial, no credit card required.

Financial data from ReWind Therapeutics

2024 2023 2022 2021
Profit/Loss -4,747,033 16 % -5,655,155 -25 % -4,511,572 -54 % -2,938,722
Equity -8,770,450 -118 % -4,023,417 -347 % 1,631,738 -73 % 6,143,310
Gross margin -120,541 50 % -241,799 18 % -294,468 -143 % 678,706
Employees 8.6 9.6 7.7 6

Publications from ReWind Therapeutics

Date Publication
17-09-2025 Resignations - Appointments (NL)
16-04-2025 Resignations - Appointments (NL)
10-03-2025 Capital - Shares (NL)
29-08-2024 Resignations - Appointments (NL)
03-01-2024 Resignations - Appointments (NL)

Frequently asked questions

What is the VAT number of ReWind Therapeutics?
The VAT number of ReWind Therapeutics is BE 0682.626.216.
Wat is the PEPPOL ID of ReWind Therapeutics?
The PEPPOL ID of ReWind Therapeutics is 0208:0682626216. Log in or start a free trial to see the full overview.
When was ReWind Therapeutics founded?
ReWind Therapeutics was founded on 29-09-2017.
What is the address of ReWind Therapeutics?
The current registered office of ReWind Therapeutics is located at Gaston Geenslaan 3, 3001 Leuven.
When was the last time ReWind Therapeutics filed their annual financial statements?
The most recent financial statements of ReWind Therapeutics were filed on 27-05-2025.
How many employees does ReWind Therapeutics have?
There are 8,6 FTEs working at ReWind Therapeutics according to the staff figures in the most recent financial statements.
What is the annual turnover of ReWind Therapeutics?
At the time of its most recent financial statements, ReWind Therapeutics did not publish any turnover figures. ReWind Therapeutics reported a gross margin of -€120,540.96.